http://orcid.org/0000-0002-0224-563X
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mihajlo Jakovljevic, Chia Jie Tan, Nathorn Chaiyakunapruk, Guilherme Silva Julian, Kei Long Cheung, Mickael Hiligsmann, Brian Godman, Sylvia Opanga, Paul A. Scuffham & Michael Gregg. (2022) Global article collection: essential reads from around the world. Journal of Medical Economics 25:1, pages 864-869.
Read now
Read now
Yoshiya Tanaka & Raj Tummala. (2021) Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials. Modern Rheumatology 31:1, pages 1-12.
Read now
Read now
Articles from other publishers (10)
Jiacai Cho, Liang Shen, Molla Huq, Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, Yi-Hsing Chen, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J Wu, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Duminda Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Shereen Oon, Sean O'Neill, Fiona Goldblatt, Kristine Pek Ling Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Cherica Tee, Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, Sandra V Navarra, Chak Sing Lau, Alberta Hoi, Eric F Morand, Mandana Nikpour & Aisha Lateef. (2023) Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study. The Lancet Rheumatology 5:10, pages e584-e593.
Crossref
Crossref
Susumu Yamazaki, Kazushi Izawa, Masakazu Matsushita, Akinori Moriichi, Dai Kishida, Hajime Yoshifuji, Ken Yamaji, Ryuta Nishikomori, Masaaki Mori & Takako Miyamae. (2023) Promoting awareness of terminology related to unmet medical needs in context of rheumatic diseases in Japan: a systematic review for evaluating unmet medical needs. Rheumatology International.
Crossref
Crossref
Julie Birt, Laure Delbecque, Daniel O’brien, Jianmin Wu, Joseph Vasey, Alex Dean, Theresa Sudaria & Aisha Vadhariya. (2023) Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States. Lupus 32:7, pages 815-826.
Crossref
Crossref
Zonglin Dai, Xinxiang Huang, Fei Yuan, Tianwang Li, Baozhao Xie, He Lin, Pingting Yang, Xueyi Li, Shuiming Xu, Jinjun Zhao, Yukai Wang, Xiang Peng, Simin Wei, Wei Huang, Jingyang Li, Jing Liang, Xiuhua Liu, Yongliang Chu, Zhiming Zhang, Renpeng Zhang, Eric H Y Lau & Zhiming Lin. (2023) Health Care–Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study. JMIR Public Health and Surveillance 9, pages e44541.
Crossref
Crossref
Haiyan Wang, Mengtao Li, Kaiwen Zou, Yilin Wang, Qiaoling Jia, Li Wang, Jiuliang Zhao, Chanyuan Wu, Qian Wang, Xinping Tian, Yanhong Wang & Xiaofeng Zeng. (2023) Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry. International Journal of Environmental Research and Public Health 20:4, pages 3522.
Crossref
Crossref
Yoshiya Tanaka, Tatsuya Atsumi, Masato Okada, Tomoya Miyamura, Tomonori Ishii, Susumu Nishiyama, Ryutaro Matsumura, Nobuya Hayashi, Gabriel Abreu, Raj Tummala, Eric F Morand & Tsutomu Takeuchi. (2023) The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis. Modern Rheumatology 33:1, pages 134-144.
Crossref
Crossref
Kenei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly Quasny, Roger A Levy, Angela R Jones-Leone, Kerry Gairy & Nobuyuki Yajima. (2022) MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT. Lupus Science & Medicine 9:1, pages e000746.
Crossref
Crossref
Juliette C. Thompson, Anadi Mahajan, David A. Scott & Kerry Gairy. (2021) The Economic Burden of Lupus Nephritis: A Systematic Literature Review. Rheumatology and Therapy 9:1, pages 25-47.
Crossref
Crossref
Miao Jiang, Aimee M Near, Barnabas Desta, Xia Wang & Edward R Hammond. (2021) Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine 8:1, pages e000503.
Crossref
Crossref
Celine Miyazaki, Nagano Katsumasa, Kuan Chih Huang & Yan Fang Liu. (2021) Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan. PLOS ONE 16:7, pages e0254807.
Crossref
Crossref